Register Cart 0

Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back Subscribe

Editorial [Hot Topic: DNA Anti-Cancer Drug Design (Executive Editor: Naijie Jing)]

Author(s): Naijie Jing

Volume 11, Issue 22, 2005

Page: [2809 - 2809] Pages: 1

DOI: 10.2174/1381612054546734

Abstract

Next »

Rights & Permissions Print Cite

Article Metrics

13

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Editorial (Hot Topic: Pharmacological and Molecular Targets in Cellular Redox Status Maintenance)
Current Pharmaceutical Design

Inhibitors of Glycine Transporter-1: Potential Therapeutics for the Treatment of CNS Disorders
Current Topics in Medicinal Chemistry

Clinical and Serological Biomarkers of Treatment’s Response in Multiple Sclerosis Patients Treated Continuously with Interferonβ-1b for More than a Decade
CNS & Neurological Disorders - Drug Targets

Bacteriophages and Phage-Derived Proteins – Application Approaches
Current Medicinal Chemistry

Telomere End Protection in Stem Cells and Cancer Cells
Current Cancer Therapy Reviews

FDG-PET/CT Imaging of Infected Bones and Prosthetic Joints
Current Molecular Imaging (Discontinued)

Synthesis of New N1Arylpiperazine Substituted Xanthine Derivatives and Evaluation of their Antioxidant and Cytotoxic Effects
Anti-Cancer Agents in Medicinal Chemistry

Steroid 5α-Reductase as a Novel Therapeutic Target for Schizophrenia and Other Neuropsychiatric Disorders
Current Pharmaceutical Design

P2X Receptors and Inflammation
Current Medicinal Chemistry

Current Status and Future Perspectives of Chemoprevention in Head and Neck Cancer
Current Cancer Drug Targets

Studies on Structures and Functions of Kinases leading to Prostate Cancer and Their Inhibitors
Current Enzyme Inhibition

Evaluation of the in vitro Antitumor Activity of Nanostructured Cyclotides in Polymers of Eudragit® L 100-55 and RS 30 D
Letters in Drug Design & Discovery

Subject Index to Volume 5
Current Drug Metabolism

Combined Dyslipidemia: Should the Focus be LDL Cholesterol or Atherogenic Dyslipidemia?
Current Pharmaceutical Design

Neprilysin and Amyloid Beta Peptide Degradation
Current Alzheimer Research

Antibody Engineering for Targeted Therapy of Cancer Recombinant Fv-Immunotoxins
Current Pharmaceutical Biotechnology

A Review of Ensemble Methods in Bioinformatics
Current Bioinformatics

Recent Advances in Gold Nanoformulations for Cancer Therapy
Current Drug Metabolism

Dietary Phytochemicals in Chemoprevention of Cancer
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents

Meet Our Editorial Board Member
Current Regenerative Medicine (Discontinued)

© 2025 Bentham Science Publishers | Privacy Policy